Tricia Schumann is a Harvard Business School alumna, was named a “30 Women to Watch” by Utah Business Magazine and is a Woman Tech Council finalist and a 2022 recipient of Top 50 Women in Finance in the U.S. for her work in fundraising. She serves on the boards of the hospital, Salt Lake Regional Medical Center, Blu Biotech, HEROIC Cybersecurity, Orriant, and Junior Achievement. With her passion for making healthcare affordable and accessible, she advises Baiya Phytopharm to seek solutions for and improve global healthcare. Tricia leverages her 15-year experience and network in management and hyper-growth businesses in U.S. healthcare industry to accelerate Baiya Phytopharm’ s growth.

Tricia Schumann
Chief Investment Officer

Tricia Schumann is a Harvard Business School alumna, was named a “30 Women to Watch” by Utah Business Magazine and is a Woman Tech Council finalist and a 2022 recipient of Top 50 Women in Finance in the U.S. for her work in fundraising. She serves on the boards of the hospital, Salt Lake Regional Medical Center, Blu Biotech, HEROIC Cybersecurity, Orriant, and Junior Achievement. With her passion for making healthcare affordable and accessible, she advises Baiya Phytopharm to seek solutions for and improve global healthcare. Tricia leverages her 15-year experience and network in management and hyper-growth businesses in U.S. healthcare industry to accelerate Baiya Phytopharm’ s growth.